Cancer Research Cancer Research Funding Available  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 5804-5807, November 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, J.
Right arrow Articles by James, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, J.
Right arrow Articles by James, C. D.

CDK4 Amplification Is an Alternative Mechanism to p16 Gene Homozygous Deletion in Glioma Cell Lines1

Ju He, James R. Allen, V. Peter Collins, M. Joan Allalunis-Turner, Roseline Godbout, Rufus S. Day, III and C. David James2

Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322 [J. H., J. R. A., C. D. J.]; Department of Pathology, Karolinska Hospital, and Ludwig Institute for Cancer Research, Stockholm Branch, S-10401 Stockholm, Sweden [V. P. C.]; and Radiobiology Program, Department of Radiation Oncology [M. J. A-T.] and Molecular Oncology Program [R. G., R. S. D.], Cross Cancer Institute, Edmonton, Alberta, Canada T6G 2G3

Recently, it has been shown that a gene encoding the cyclin-dependent kinase 4 inhibitory protein, p16, is frequently targeted for homozygous deletions in several types of tumor cell lines, including those established from malignant gliomas. Here we have examined 32 glioma cell lines for amplification-associated overexpression of the CDK4 gene as an alternative mechanism for abrogating the growth-regulatory effects of p16. Two of the cell lines revealed high-level expression of CDK4 in association with gene amplification, and this alteration was observed among the 10 cases having intact p16 genes. Consequently, 24 of 32 glioma cell lines revealed one of two alternative genetic alterations, each of which indicates that increased cdk4 kinase activity is important to glial tumor development.

1 This work was supported by grants from the National Cancer Institute (CA55728), the Swedish Cancer Society, and the National Cancer Institute of Canada, and by generous gifts from the Brain Tumor Foundation for Children of Georgia.

2 To whom requests for reprints should be addressed, at Department of Neurosurgery, Emory University School of Medicine, 1327 Clifton Rd., NE, Atlanta, GA 30322.

Received 9/ 2/94. Accepted 10/ 5/94.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
W. A. Braden, J. M. Lenihan, Z. Lan, K. S. Luce, W. Zagorski, E. Bosco, M. F. Reed, J. G. Cook, and E. S. Knudsen
Distinct Action of the Retinoblastoma Pathway on the DNA Replication Machinery Defines Specific Roles for Cyclin-Dependent Kinase Complexes in Prereplication Complex Assembly and S-Phase Progression
Mol. Cell. Biol., October 15, 2006; 26(20): 7667 - 7681.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. I. Shapiro
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
J. Clin. Oncol., April 10, 2006; 24(11): 1770 - 1783.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Hernandez, S. Bea, M. Pinyol, G. Ott, T. Katzenberger, A. Rosenwald, F. Bosch, A. Lopez-Guillermo, J. Delabie, D. Colomer, et al.
CDK4 and MDM2 Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-type INK4a/ARF Locus
Cancer Res., March 15, 2005; 65(6): 2199 - 2206.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. L. Miliani de Marval, E. Macias, R. Rounbehler, P. Sicinski, H. Kiyokawa, D. G. Johnson, C. J. Conti, and M. L. Rodriguez-Puebla
Lack of Cyclin-Dependent Kinase 4 Inhibits c-myc Tumorigenic Activities in Epithelial Tissues
Mol. Cell. Biol., September 1, 2004; 24(17): 7538 - 7547.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Narita, M. Nagane, K. Mishima, H-J. S. Huang, F. B. Furnari, and W. K. Cavenee
Mutant Epidermal Growth Factor Receptor Signaling Down-Regulates p27 through Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway in Glioblastomas
Cancer Res., November 15, 2002; 62(22): 6764 - 6769.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. L. Rodriguez-Puebla, P. L. Miliani de Marval, M. LaCava, D. S. Moons, H. Kiyokawa, and C. J. Conti
cdk4 Deficiency Inhibits Skin Tumor Development but Does Not Affect Normal Keratinocyte Proliferation
Am. J. Pathol., August 1, 2002; 161(2): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. L. Miliani de Marval, I. B. Gimenez-Conti, M. LaCava, L. A. Martinez, C. J. Conti, and M. L. Rodriguez-Puebla
Transgenic Expression of Cyclin-Dependent Kinase 4 Results in Epidermal Hyperplasia, Hypertrophy, and Severe Dermal Fibrosis
Am. J. Pathol., July 1, 2001; 159(1): 369 - 379.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Lewis, W. Chinswangwatanakul, B. Zheng, S. B. Marley, D. X. Nguyen, N. C. P. Cross, L. Banerji, J. Glassford, N. S. B. Thomas, J. M. Goldman, et al.
The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells
Blood, May 1, 2001; 97(9): 2604 - 2610.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
X. Chen, M. Lowe, T. Herliczek, M. J. Hall, C. Danes, D. A. Lawrence, and K. Keyomarsi
Protection of Normal Proliferating Cells Against Chemotherapy by Staurosporine-Mediated, Selective, and Reversible G1 Arrest
J Natl Cancer Inst, December 20, 2000; 92(24): 1999 - 2008.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Tsugu, K. Sakai, P. B. Dirks, S. Jung, R. Weksberg, Y.-L. Fei, S. Mondal, S. Ivanchuk, C. Ackerley, P. A. Hamel, et al.
Expression of p57KIP2 Potently Blocks the Growth of Human Astrocytomas and Induces Cell Senescence
Am. J. Pathol., September 1, 2000; 157(3): 919 - 932.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
R. N. Wiltshire, B.K. A. Rasheed, H. S. Friedman, A. H. Friedman, and S. H. Bigner
Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classification
Neuro-oncol, July 1, 2000; 2(3): 164 - 173.
[Abstract] [PDF]


Home page
Cell Growth Differ.Home page
J. Fuxe, G. Akusjärvi, H. M. Goike, G. Roos, V. P. Collins, and R. F. Pettersson
Adenovirus-mediated Overexpression of p15INK4B Inhibits Human Glioma Cell Growth, Induces Replicative Senescence, and Inhibits Telomerase Activity Similarly to p16INK4A
Cell Growth Differ., July 1, 2000; 11(7): 373 - 384.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
M. Omura-Minamisawa, M. B. Diccianni, A. Batova, R. C. Chang, L. J. Bridgeman, J. Yu, J. Pullen, W. P. Bowman, and A. L. Yu
Universal Inactivation of Both p16 and p15 but not Downstream Components Is an Essential Event in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia
Clin. Cancer Res., April 1, 2000; 6(4): 1219 - 1228.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
E. C. Holland
A Mouse Model for Glioma: Biology, Pathology, and Therapeutic Opportunities
Toxicol Pathol, January 1, 2000; 28(1): 171 - 177.
[Abstract] [PDF]


Home page
Cancer Res.Home page
K. Ichimura, M. B. Bolin, H. M. Goike, E. E. Schmidt, A. Moshref, and V. P. Collins
Deregulation of the p14ARF/MDM2/p53 Pathway Is a Prerequisite for Human Astrocytic Gliomas with G1-S Transition Control Gene Abnormalities
Cancer Res., January 1, 2000; 60(2): 417 - 424.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
T. Kusume, H. Tsuda, M. Kawabata, T. Inoue, N. Umesaki, T. Suzuki, and K. Yamamoto
The p16-Cyclin D1/CDK4-pRb Pathway and Clinical Outcome in Epithelial Ovarian Cancer
Clin. Cancer Res., December 1, 1999; 5(12): 4152 - 4157.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Y. Chung, Y. Saeki, and E. A. Chiocca
B-myb Promoter Retargeting of Herpes Simplex Virus gamma 34.5 Gene-Mediated Virulence toward Tumor and Cycling Cells
J. Virol., September 1, 1999; 73(9): 7556 - 7564.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
S. H. Bigner, M. R. Matthews, B. K. A. Rasheed, R. N. Wiltshire, H. S. Friedman, A. H. Friedman, T. T. Stenzel, D. M. Dawes, R. E. McLendon, and D. D. Bigner
Molecular Genetic Aspects of Oligodendrogliomas Including Analysis by Comparative Genomic Hybridization
Am. J. Pathol., August 1, 1999; 155(2): 375 - 386.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Parry, D. Mahony, K. Wills, and E. Lees
Cyclin D-CDK Subunit Arrangement Is Dependent on the Availability of Competing INK4 and p21 Class Inhibitors
Mol. Cell. Biol., March 1, 1999; 19(3): 1775 - 1783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H.-X. An, M. W. Beckmann, G. Reifenberger, H. G. Bender, and D. Niederacher
Gene Amplification and Overexpression of CDK4 in Sporadic Breast Carcinomas Is Associated with High Tumor Cell Proliferation
Am. J. Pathol., January 1, 1999; 154(1): 113 - 118.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
E. C. Holland, W. P. Hively, V. Gallo, and H. E. Varmus
Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes
Genes & Dev., December 1, 1998; 12(23): 3644 - 3649.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
E. C. Holland, W. P. Hively, R. A. DePinho, and H. E. Varmus
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice
Genes & Dev., December 1, 1998; 12(23): 3675 - 3685.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
G. Brooks, R. A Poolman, and J.-M. Li
Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors
Cardiovasc Res, August 1, 1998; 39(2): 301 - 311.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Lee, M. J. Ha, J. Lee, P. Nguyen, Y. H. Choi, F. Pirnia, W.-K. Kang, X.-F. Wang, S.-J. Kim, and J. B. Trepel
Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21WAF1/CIP1 in Human Prostate Carcinoma Cells
J. Biol. Chem., April 24, 1998; 273(17): 10618 - 10623.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. B. Furnari, H. Lin, H.-J. S. Huang, and W. K. Cavenee
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
PNAS, November 11, 1997; 94(23): 12479 - 12484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Lahti, H. Li, and V. J. Kidd
Elimination of Cyclin D1 in Vertebrate Cells Leads to an Altered Cell Cycle Phenotype, Which Is Rescued by Overexpression of Murine Cyclins D1, D2, or D3 but Not by a Mutant Cyclin D1
J. Biol. Chem., April 18, 1997; 272(16): 10859 - 10869.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T Wolfel, M Hauer, J Schneider, M Serrano, C Wolfel, E Klehmann-Hieb, E De Plaen, T Hankeln, K. Meyer zum Buschenfelde, and D Beach
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
Science, September 1, 1995; 269(5228): 1281 - 1284.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.